Drug General Information
Drug ID	D0N2NI
Drug Name	Entrectinib
Indication	Mammary analogue secretory carcinoma [ICD10:C07]		Phase 1	[1572606]
	Colorectal cancer [ICD10:C18-C21]		Phase 1	[1572606]
Structure		Download 2D MOL 3D MOL
Drug Resistance Mutation (DRM)
DRM	DRM Info
References
Ref 1572606	Safety and Antitumor Activity of the Multitargeted Pan-TRK, ROS1, and ALK Inhibitor Entrectinib: Combined Results from Two Phase I Trials (ALKA-372-001 and STARTRK-1).

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.